Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
On Thursday, Cathie Wood's Ark Invest made a significant move by reducing its stake in Tesla, despite a recent bullish outlook on the company's potential in the autonomous taxi sector.
10x Genomics Shares Fall After JPMorgan Downgrade
10x Genomics (TXG) shares were down 8.7% in recent Thursday trading after JPMorgan downgraded the company's stock to neutral from overweight and cut the price target to $20 from $40.Intraday trading
Express News | 10x Genomics Shares Are Trading Lower After JP Morgan Downgraded the Stock From Overweight to Neutral and Lowered Its Price Target From $40 to $20
10x Genomics Is Maintained at Neutral by B of A Securities
10x Genomics Is Maintained at Neutral by B of A
10x Genomics Price Target Cut to $25.00/Share From $36.00 by B of A Securities
10x Genomics Price Target Cut to $25.00/Share From $36.00 by B of A
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Cuts Target Price to $25
BofA Securities analyst Michael Ryskin maintains $10x Genomics(TXG.US)$ with a hold rating, and adjusts the target price from $36 to $25.According to TipRanks data, the analyst has a success rate of 5
Bruker: CosMx Products Once Again Available to German Scientific Instrument Customers >BRKR
Bruker: CosMx Products Once Again Available to German Scientific Instrument Customers >
Bruker: Suspension Due to Ongoing Patent Litigation With 10x Genomics, During an Appeal Process in Germany >BRKR
Bruker: Suspension Due to Ongoing Patent Litigation With 10x Genomics, During an Appeal Process in Germany >
Express News | 10X Genomics Inc : BofA Global Research Cuts Price Objective to $25 From $36
J.P. Morgan Downgrades 10x Genomics(TXG.US) to Hold Rating, Cuts Target Price to $20
J.P. Morgan analyst Rachel Vatnsdal downgrades $10x Genomics(TXG.US)$ to a hold rating, and adjusts the target price from $40 to $20.According to TipRanks data, the analyst has a success rate of 33.7%
Express News | 10X Genomics Inc : JP Morgan Cuts Target Price to $20 From $40
Express News | 10X Genomics Inc : JP Morgan Cuts to Neutral From Overweight
Does 10x Genomics (TXG) Have the Potential to Rally 85.65% as Wall Street Analysts Expect?
12 Analysts Assess 10x Genomics: What You Need To Know
In the preceding three months, 12 analysts have released ratings for 10x Genomics (NASDAQ:TXG), presenting a wide array of perspectives from bullish to bearish.The following table encapsulates their
10x Genomics Is Maintained at Buy by Stifel
10x Genomics Is Maintained at Buy by
10x Genomics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 38.81% Stifel $53 → $25 Maintains Buy 07/10/2024 38.81% Deutsche Bank $55 → $25 Downgrades
Stifel Maintains 10x Genomics(TXG.US) With Buy Rating, Cuts Target Price to $25
Stifel analyst Daniel Arias maintains $10x Genomics(TXG.US)$ with a buy rating, and adjusts the target price from $53 to $25.According to TipRanks data, the analyst has a success rate of 36.4% and a
Express News | 10X Genomics Inc : Stifel Cuts Target Price to $25 From $53
Express News | 10X Genomics Inc : TD Cowen Cuts Target Price to $20 From $32
10x Genomics (TXG) Surges 8.2%: Is This an Indication of Further Gains?